Yang Zhao

Summary

Publications

  1. doi request reprint Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients
    Y Zhao
    Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
    Osteoporos Int 24:2525-33. 2013
  2. doi request reprint Clinical and economic characteristics of hip fracture patients with and without muscle atrophy/weakness in the United States
    Yang Zhao
    Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936 1080, USA
    Arch Osteoporos 8:127. 2013

Detail Information

Publications2

  1. doi request reprint Association between teriparatide adherence and healthcare utilization and costs in real-world US kyphoplasty/vertebroplasty patients
    Y Zhao
    Novartis Pharmaceuticals Corporation, East Hanover, NJ, USA
    Osteoporos Int 24:2525-33. 2013
    ..Among KV patients newly initiating teriparatide, significantly increased pharmacy costs associated with high teriparatide adherence were offset by significantly lower inpatient utilization and medical costs...
  2. doi request reprint Clinical and economic characteristics of hip fracture patients with and without muscle atrophy/weakness in the United States
    Yang Zhao
    Novartis Pharmaceuticals Corporation, One Health Plaza, East Hanover, NJ 07936 1080, USA
    Arch Osteoporos 8:127. 2013
    ..This retrospective analysis of hip fracture patients with and without muscle atrophy/weakness (MAW) revealed that those with MAW had significantly higher healthcare utilization and costs compared with hip fracture patients without MAW...